The Washington Post, July 26, 2017: Essure was marketed as an easy, non-invasive permanent contraception (sterilization), but many women reported pain, serious harm requiring surgery, and pregnancies. It wasn’t until patients and public health experts like NCHR met with FDA officials that the agency added warnings. Some women needed surgery to remove the device, and lawsuits claimed FDA approved Essure based on poorly conducted clinical trials.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
U.S. House Passes Bill to Lengthen Time to Report Medical Device Malfunctions
The Star Tribune: July 12, 2017. The U.S. House passed a bill on Wednesday that would triple the time medical device companies have to report malfunctions.
Read More »U.S. House Passes Bill to Lengthen Time to Report Medical Device Malfunctions
The Star Tribune, July 12, 2017. An bill passed by the U.S. House on Wednesday would give medical device companies more time to report malfunctions.
Read More »FDA Deal Would Relax Rules on Reporting Medical Device Problems
The New York Times, July 11, 2017. Medical device makers might be able to delay reporting dangerous malfunctions to the FDA under a proposed agreement.
Read More »FDA Eases Notice Requirement on More Than 1,000 Medical Devices
Bloomberg, July 10 2017: The FDA removed evidence requirements for over 1,000 moderate-risk medical devices. This has pleased AdvaMed and other companies but it means even less information for patients, and we agree that it could result in less safe medical devices.
Read More »